Microchimerism in Behçet's disease

International Journal of Dermatology

Volumn 53, Issue 7, 2014, Pages 832-837

  Alp, Ruken ^a   Guney, Aysequl U ^a   Tursen, Umit ^a   Kaya, Tamer ^a   Tursen, Belma ^b   Erdal, Mehmet E ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN STATE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; EYE INJURY; FEMALE; FOOT AND MOUTH DISEASE; GENITAL ULCER; HUMAN; LUNG LESION; MAJOR CLINICAL STUDY; MICROCHIMERISM; SKIN DEFECT; SRY GENE; VASCULITIS; ADOLESCENT; AUTOIMMUNE DISEASE; CHIMERA; GENETICS; MALE; MIDDLE AGED; NUCLEAR FAMILY; YOUNG ADULT;

SRY PROTEIN, HUMAN; TESTIS DETERMINING FACTOR;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; BEHCET SYNDROME; CHIMERISM; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR FAMILY; SEX-DETERMINING REGION Y PROTEIN; YOUNG ADULT;

EID: 84902774119     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05804.x     Document Type: Article

References (32)

1. Behçet H. Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Monatsschr Wochenschr 1937; 105: 1152-1157.
2. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-427.
3. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003; 42: 346-351.
4. Regnier S, Aractingi S. Microchimerism and autoimmune diseases. Eur J Intern Med 2002; 13: 365-368.
5. Endo Y, Negishi I, Ishikawa O. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome. Rheumatology 2002; 41: 490-495.
6. Hovinga ICLK, Koopmans M, Baelde HJ, et al. Tissue chimerism in systemic lupus erythematosus is related to injury. Ann Rheum Dis 2007; 66: 1568-1573.
7. Mosca M, Giuliano T, Curcio M, et al. Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis. Ann Rheum Dis 2009; 68: 155-156.
8. Artlett CM. Pathophysiology of fetal microchimeric cells. Clin Chim Acta 2005; 360: 1-8.
9. Türsen U. Pathophysiology of the Behçet's disease. Patholog Res Int 2012; 2012: 493015.
10. Bianchi DW, Zickwolf G, Weil G, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years post partum. Proc Natl Acad Sci U S A 1996; 93: 705-707.
11. Lambert NC, Evans PC, Hashizumi TL, et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA*0501: implications in autoimmunity. J Immunol 2000; 164: 5545-5548.
12. Rubbia-Brandt L, Philippeaux MM, Chavez S, et al. FISH for Y chromosome in women with primary biliary cirrhosis: lack of evidence of leucocyte microchimerism. Hepatology 1999; 30: 821-822.
13. Aractingi S, Uzan S, Dausset J, et al. Microchimerism in human diseases. Trend Immunol Today 2000; 116: 3-5.
14. Nelson J, Lambert NC. Microchimerism in rheumatic diseases. Joint Bone Spine 2001; 68: 290-296.
15. Leduc M, Aractingi S, Khosrotehrani K. Fetal cell microchimerism, lymphopoiesis, and autoimmunity. Arch Immunol Ther Exp (Warsz) 2009; 57: 325-329.
16. Hirohata S, Kikuchi H. Behçet's disease. Arthritis Res Ther 2003; 5: 139-146.
17. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6: 294-298.
18. Stevens AM, Tsao BP, Hahn BH, et al. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2768-2773.
19. Kaya TI, Tursen U, Gurler A, et al. Association of class I HLA antigens with the manifestations of Turkish Behçet' s disease patients. Clin Exp Dermatol 2002; 27: 498-501.
20. Wang Y, Iwatani H, Ito T, et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004; 325: 961-967.
21. Giugliano E, Cagnazzo E, Servello T, et al. Pruritic urticarial papules and plaques of pregnancy. J Obstet Gynaecol 2012; 32: 301-302.
22. Lipozenčić J, Ljubojevic S, Bukvić-Mokos Z. Pemphigoid gestationis. Clin Dermatol 2012; 30: 51-55.
23. Bassukas ID. Is erythema toxicum neonatorum a mild self-limited acute cutaneous graft-versus-host-reaction from maternal-to-fetal lymphocyte transfer? Med Hypotheses 1992; 38: 334-338.
24. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 2004; 3: 454-463.
25. Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996; 39: 191-194.
26. Khosrotehrani K, Reyes RR, Johnson KL, et al. Presence of chimeric maternally-derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides. J Invest Dermatol 2006; 126: 345-348.
27. Alpsoy E, Uzun S, Akman A, et al. Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease. J Eur Acad Dermatol Venereol 2003; 17: 521-524.
28. de Smet MD, Dayan M. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthalmol Vis Sci 2000; 41: 3480-3484.
29. Hegab S, Al-Mutawa S. Immunopathogenesis of Behçet's disease. Clin Immunol 2000; 96: 174-186.
30. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
31. Direskeneli H, Keser G, D''Cruz D, et al. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol 1995; 14: 55-61.
32. Hu W, Hasan A, Wilson A, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein derived peptide. Eur J Immunol 1998; 28: 2444-2455.